Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 58 entries
Sorted by: Best Match Show Resources per page
What do cardiologists know about the effects of cardiovascular agents on sexual function? A survey among Dutch cardiologists. Part I.

Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation

Nicolai MP, Liem SS, Both S, Pelger RC, Putter H, Schalij MJ, Elzevier HW.
PMID: 24072687
Neth Heart J. 2013 Dec;21(12):540-4. doi: 10.1007/s12471-013-0471-2.

INTRODUCTION: Several cardiovascular agents, such as diuretics and β-blockers, can negatively affect sexual function, leading to noncompliance with therapy. Others such as angiotensin II receptor blockers (ARBs) can improve patients' sexual function.AIMS: We aimed to gain insight into cardiologists'...

Cite
Nicolai MP, Liem SS, Both S, et al. What do cardiologists know about the effects of cardiovascular agents on sexual function? A survey among Dutch cardiologists. Part I. Neth Heart J. 2013;21(12):540-4doi: 10.1007/s12471-013-0471-2.
Nicolai, M. P., Liem, S. S., Both, S., Pelger, R. C., Putter, H., Schalij, M. J., & Elzevier, H. W. (2013). What do cardiologists know about the effects of cardiovascular agents on sexual function? A survey among Dutch cardiologists. Part I. Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation, 21(12), 540-4. https://doi.org/10.1007/s12471-013-0471-2
Nicolai, M P J, et al. "What do cardiologists know about the effects of cardiovascular agents on sexual function? A survey among Dutch cardiologists. Part I." Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation vol. 21,12 (2013): 540-4. doi: https://doi.org/10.1007/s12471-013-0471-2
Nicolai MP, Liem SS, Both S, Pelger RC, Putter H, Schalij MJ, Elzevier HW. What do cardiologists know about the effects of cardiovascular agents on sexual function? A survey among Dutch cardiologists. Part I. Neth Heart J. 2013 Dec;21(12):540-4. doi: 10.1007/s12471-013-0471-2. PMID: 24072687; PMCID: PMC3833914.
Copy Download .nbib Format: NLM
Uso del Registro de Solicitudes de Medicamentos no Incluidos en el Listado de Medicamentos Esenciales como Nueva Fuente de Información en los Sistemas Nacionales de Farmacovigilancia.

Value in health regional issues

Buendía JA, Zuluaga Salazar AF, Vacca González CP.
PMID: 29702770
Value Health Reg Issues. 2013 Dec;2(3):357-360. doi: 10.1016/j.vhri.2013.10.005. Epub 2013 Dec 12.

OBJECTIVE: To describe the frequency of adverse drugs events (ADEs) as possible causes of request of drugs not included in national essential Medicines list in Colombia.METHODS: This was a descriptive study developed in a private medical insurance company in...

Cite
Buendía JA, Zuluaga Salazar AF, Vacca González CP. Uso del Registro de Solicitudes de Medicamentos no Incluidos en el Listado de Medicamentos Esenciales como Nueva Fuente de Información en los Sistemas Nacionales de Farmacovigilancia. Value Health Reg Issues. 2013;2(3):357-360doi: 10.1016/j.vhri.2013.10.005.
Buendía, J. A., Zuluaga Salazar, A. F., & Vacca González, C. P. (2013). Uso del Registro de Solicitudes de Medicamentos no Incluidos en el Listado de Medicamentos Esenciales como Nueva Fuente de Información en los Sistemas Nacionales de Farmacovigilancia. Value in health regional issues, 2(3), 357-360. https://doi.org/10.1016/j.vhri.2013.10.005
Buendía, Jefferson Antonio, et al. "Uso del Registro de Solicitudes de Medicamentos no Incluidos en el Listado de Medicamentos Esenciales como Nueva Fuente de Información en los Sistemas Nacionales de Farmacovigilancia." Value in health regional issues vol. 2,3 (2013): 357-360. doi: https://doi.org/10.1016/j.vhri.2013.10.005
Buendía JA, Zuluaga Salazar AF, Vacca González CP. Uso del Registro de Solicitudes de Medicamentos no Incluidos en el Listado de Medicamentos Esenciales como Nueva Fuente de Información en los Sistemas Nacionales de Farmacovigilancia. Value Health Reg Issues. 2013 Dec;2(3):357-360. doi: 10.1016/j.vhri.2013.10.005. Epub 2013 Dec 12. PMID: 29702770.
Copy Download .nbib Format: NLM
Use of Extracorporeal Membrane Oxygenation in Acutely Poisoned Pediatric Patients in United States: A Retrospective Analysis of the Extracorporeal Life Support Registry From 2003 to 2019.

Critical care medicine

Di Nardo M, Alunni Fegatelli D, Marano M, Danoff J, Kim HK.
PMID: 34995213
Crit Care Med. 2022 Jan 07; doi: 10.1097/CCM.0000000000005436. Epub 2022 Jan 07.

OBJECTIVES: To describe the use of extracorporeal membrane oxygenation (ECMO) in the management of pediatric poisoning in the United States and to identify predictors of mortality.DESIGN: Retrospective cohort study.SETTING: Data reported to the Extracorporeal Life Support Organization by 76...

Cite
Di Nardo M, Alunni Fegatelli D, Marano M, et al. Use of Extracorporeal Membrane Oxygenation in Acutely Poisoned Pediatric Patients in United States: A Retrospective Analysis of the Extracorporeal Life Support Registry From 2003 to 2019. Crit Care Med. 2022;doi: 10.1097/CCM.0000000000005436.
Di Nardo, M., Alunni Fegatelli, D., Marano, M., Danoff, J., & Kim, H. K. (2022). Use of Extracorporeal Membrane Oxygenation in Acutely Poisoned Pediatric Patients in United States: A Retrospective Analysis of the Extracorporeal Life Support Registry From 2003 to 2019. Critical care medicine, . https://doi.org/10.1097/CCM.0000000000005436
Di Nardo, Matteo, et al. "Use of Extracorporeal Membrane Oxygenation in Acutely Poisoned Pediatric Patients in United States: A Retrospective Analysis of the Extracorporeal Life Support Registry From 2003 to 2019." Critical care medicine vol. (2022). doi: https://doi.org/10.1097/CCM.0000000000005436
Di Nardo M, Alunni Fegatelli D, Marano M, Danoff J, Kim HK. Use of Extracorporeal Membrane Oxygenation in Acutely Poisoned Pediatric Patients in United States: A Retrospective Analysis of the Extracorporeal Life Support Registry From 2003 to 2019. Crit Care Med. 2022 Jan 07; doi: 10.1097/CCM.0000000000005436. Epub 2022 Jan 07. PMID: 34995213.
Copy Download .nbib Format: NLM
Use of Extracorporeal Membrane Oxygenation in Acutely Poisoned Pediatric Patients in United States: A Retrospective Analysis of the Extracorporeal Life Support Registry From 2003 to 2019.

Critical care medicine

Di Nardo M, Alunni Fegatelli D, Marano M, Danoff J, Kim HK.
PMID: 34995213
Crit Care Med. 2022 Jan 07; doi: 10.1097/CCM.0000000000005436. Epub 2022 Jan 07.

OBJECTIVES: To describe the use of extracorporeal membrane oxygenation (ECMO) in the management of pediatric poisoning in the United States and to identify predictors of mortality.DESIGN: Retrospective cohort study.SETTING: Data reported to the Extracorporeal Life Support Organization by 76...

Cite
Di Nardo M, Alunni Fegatelli D, Marano M, et al. Use of Extracorporeal Membrane Oxygenation in Acutely Poisoned Pediatric Patients in United States: A Retrospective Analysis of the Extracorporeal Life Support Registry From 2003 to 2019. Crit Care Med. 2022;doi: 10.1097/CCM.0000000000005436.
Di Nardo, M., Alunni Fegatelli, D., Marano, M., Danoff, J., & Kim, H. K. (2022). Use of Extracorporeal Membrane Oxygenation in Acutely Poisoned Pediatric Patients in United States: A Retrospective Analysis of the Extracorporeal Life Support Registry From 2003 to 2019. Critical care medicine, . https://doi.org/10.1097/CCM.0000000000005436
Di Nardo, Matteo, et al. "Use of Extracorporeal Membrane Oxygenation in Acutely Poisoned Pediatric Patients in United States: A Retrospective Analysis of the Extracorporeal Life Support Registry From 2003 to 2019." Critical care medicine vol. (2022). doi: https://doi.org/10.1097/CCM.0000000000005436
Di Nardo M, Alunni Fegatelli D, Marano M, Danoff J, Kim HK. Use of Extracorporeal Membrane Oxygenation in Acutely Poisoned Pediatric Patients in United States: A Retrospective Analysis of the Extracorporeal Life Support Registry From 2003 to 2019. Crit Care Med. 2022 Jan 07; doi: 10.1097/CCM.0000000000005436. Epub 2022 Jan 07. PMID: 34995213.
Copy Download .nbib Format: NLM
Drug-associated cardiovascular risks: A retrospective evaluation of withdrawn drugs.

Northern clinics of Istanbul

Kocadal K, Saygi S, Alkas FB, Sardas S.
PMID: 31297490
North Clin Istanb. 2018 Sep 05;6(2):196-202. doi: 10.14744/nci.2018.44977. eCollection 2019.

A considerable number of drugs were withdrawn from the world market in the last decades due to safety reasons. A retrospective review of withdrawals is important in determining the adequacy of regulations regarding the safety and efficacy of drugs....

Cite
Kocadal K, Saygi S, Alkas FB, et al. Drug-associated cardiovascular risks: A retrospective evaluation of withdrawn drugs. North Clin Istanb. 2018;6(2):196-202doi: 10.14744/nci.2018.44977.
Kocadal, K., Saygi, S., Alkas, F. B., & Sardas, S. (2019). Drug-associated cardiovascular risks: A retrospective evaluation of withdrawn drugs. Northern clinics of Istanbul, 6(2), 196-202. https://doi.org/10.14744/nci.2018.44977
Kocadal, Kumsal, et al. "Drug-associated cardiovascular risks: A retrospective evaluation of withdrawn drugs." Northern clinics of Istanbul vol. 6,2 (2019): 196-202. doi: https://doi.org/10.14744/nci.2018.44977
Kocadal K, Saygi S, Alkas FB, Sardas S. Drug-associated cardiovascular risks: A retrospective evaluation of withdrawn drugs. North Clin Istanb. 2018 Sep 05;6(2):196-202. doi: 10.14744/nci.2018.44977. eCollection 2019. PMID: 31297490; PMCID: PMC6593908.
Copy Download .nbib Format: NLM
Communication of Treatment Rankings Obtained From Network Meta-Analysis Using Data Visualization.

Circulation. Cardiovascular quality and outcomes

Naci H.
PMID: 27601459
Circ Cardiovasc Qual Outcomes. 2016 Sep;9(5):605-8. doi: 10.1161/CIRCOUTCOMES.116.002874. Epub 2016 Sep 06.

No abstract available.

Cite
Naci H. Communication of Treatment Rankings Obtained From Network Meta-Analysis Using Data Visualization. Circ Cardiovasc Qual Outcomes. 2016;9(5):605-8doi: 10.1161/CIRCOUTCOMES.116.002874.
Naci, H. (2016). Communication of Treatment Rankings Obtained From Network Meta-Analysis Using Data Visualization. Circulation. Cardiovascular quality and outcomes, 9(5), 605-8. https://doi.org/10.1161/CIRCOUTCOMES.116.002874
Naci, Huseyin. "Communication of Treatment Rankings Obtained From Network Meta-Analysis Using Data Visualization." Circulation. Cardiovascular quality and outcomes vol. 9,5 (2016): 605-8. doi: https://doi.org/10.1161/CIRCOUTCOMES.116.002874
Naci H. Communication of Treatment Rankings Obtained From Network Meta-Analysis Using Data Visualization. Circ Cardiovasc Qual Outcomes. 2016 Sep;9(5):605-8. doi: 10.1161/CIRCOUTCOMES.116.002874. Epub 2016 Sep 06. PMID: 27601459.
Copy Download .nbib Format: NLM
Cardiovascular Complications of Acetylcholinesterase Inhibitors in Patients with Alzheimer's Disease: A Narrative Review.

Annals of geriatric medicine and research

Young S, Chung E, Chen MA.
PMID: 34610666
Ann Geriatr Med Res. 2021 Sep;25(3):170-177. doi: 10.4235/agmr.21.0079. Epub 2021 Sep 29.

While acetylcholinesterase inhibitors are used to treat a wide range of patients with Alzheimer's disease, acetylcholinesterase inhibitor use has also been associated with a variety of cardiovascular complications, including bradycardia and syncope. Herein, we review the pathophysiology and clinical...

Cite
Young S, Chung E, Chen MA. Cardiovascular Complications of Acetylcholinesterase Inhibitors in Patients with Alzheimer's Disease: A Narrative Review. Ann Geriatr Med Res. 2021;25(3):170-177doi: 10.4235/agmr.21.0079.
Young, S., Chung, E., & Chen, M. A. (2021). Cardiovascular Complications of Acetylcholinesterase Inhibitors in Patients with Alzheimer's Disease: A Narrative Review. Annals of geriatric medicine and research, 25(3), 170-177. https://doi.org/10.4235/agmr.21.0079
Young, Sara, et al. "Cardiovascular Complications of Acetylcholinesterase Inhibitors in Patients with Alzheimer's Disease: A Narrative Review." Annals of geriatric medicine and research vol. 25,3 (2021): 170-177. doi: https://doi.org/10.4235/agmr.21.0079
Young S, Chung E, Chen MA. Cardiovascular Complications of Acetylcholinesterase Inhibitors in Patients with Alzheimer's Disease: A Narrative Review. Ann Geriatr Med Res. 2021 Sep;25(3):170-177. doi: 10.4235/agmr.21.0079. Epub 2021 Sep 29. PMID: 34610666; PMCID: PMC8497945.
Copy Download .nbib Format: NLM
Search Strategies Used for Meta-Analyses Published on Cardiovascular Drug Therapy.

Therapeutic innovation & regulatory science

Armstrong DL, Suda KJ, Wu L.
PMID: 30235522
Ther Innov Regul Sci. 2013 Jul;47(4):484-488. doi: 10.1177/2168479013487354.

PURPOSE: Meta-analyses are routinely shaping patient care decisions. However, it is unknown whether meta-analyses are increasing in cardiology or whether complete search strategies are used. The purpose of this study was to assess the quality of search strategies of...

Cite
Armstrong DL, Suda KJ, Wu L. Search Strategies Used for Meta-Analyses Published on Cardiovascular Drug Therapy. Ther Innov Regul Sci. 2013;47(4):484-488doi: 10.1177/2168479013487354.
Armstrong, D. L., Suda, K. J., & Wu, L. (2013). Search Strategies Used for Meta-Analyses Published on Cardiovascular Drug Therapy. Therapeutic innovation & regulatory science, 47(4), 484-488. https://doi.org/10.1177/2168479013487354
Armstrong, Drew L, et al. "Search Strategies Used for Meta-Analyses Published on Cardiovascular Drug Therapy." Therapeutic innovation & regulatory science vol. 47,4 (2013): 484-488. doi: https://doi.org/10.1177/2168479013487354
Armstrong DL, Suda KJ, Wu L. Search Strategies Used for Meta-Analyses Published on Cardiovascular Drug Therapy. Ther Innov Regul Sci. 2013 Jul;47(4):484-488. doi: 10.1177/2168479013487354. PMID: 30235522.
Copy Download .nbib Format: NLM
Using Zebrafish for High-Throughput Screening of Novel Cardiovascular Drugs.

JACC. Basic to translational science

Kithcart A, MacRae CA.
PMID: 30167552
JACC Basic Transl Sci. 2017 Feb 27;2(1):1-12. doi: 10.1016/j.jacbts.2017.01.004. eCollection 2017 Feb.

Cardiovascular diseases remain a major challenge for modern drug discovery. The diseases are chronic, complex, and the result of sophisticated interactions between genetics and environment involving multiple cell types and a host of systemic factors. The clinical events are...

Cite
Kithcart A, MacRae CA. Using Zebrafish for High-Throughput Screening of Novel Cardiovascular Drugs. JACC Basic Transl Sci. 2017;2(1):1-12doi: 10.1016/j.jacbts.2017.01.004.
Kithcart, A., & MacRae, C. A. (2017). Using Zebrafish for High-Throughput Screening of Novel Cardiovascular Drugs. JACC. Basic to translational science, 2(1), 1-12. https://doi.org/10.1016/j.jacbts.2017.01.004
Kithcart, Aaron, and MacRae, Calum A. "Using Zebrafish for High-Throughput Screening of Novel Cardiovascular Drugs." JACC. Basic to translational science vol. 2,1 (2017): 1-12. doi: https://doi.org/10.1016/j.jacbts.2017.01.004
Kithcart A, MacRae CA. Using Zebrafish for High-Throughput Screening of Novel Cardiovascular Drugs. JACC Basic Transl Sci. 2017 Feb 27;2(1):1-12. doi: 10.1016/j.jacbts.2017.01.004. eCollection 2017 Feb. PMID: 30167552; PMCID: PMC6113531.
Copy Download .nbib Format: NLM
Age- and Sex-related Prevalence and Drug Utilization Pattern in the Management of Type 2 Diabetes Mellitus and its Comorbidity with Cardiovascular Diseases: A Comparative Study.

Indian journal of pharmaceutical sciences

Das S, Haroled Peter PL, Bhavani ML, Naresh P, Ramana MV.
PMID: 26664065
Indian J Pharm Sci. 2015 Jul-Aug;77(4):478-84. doi: 10.4103/0250-474x.164776.

A cross-sectional study of 250 cases of type 2 diabetes management was conducted in a governmental tertiary care hospital of urban south India to determine the comparative prevalence of type 2 diabetes and its comorbidity with cardiovascular diseases in...

Cite
Das S, Haroled Peter PL, Bhavani ML, et al. Age- and Sex-related Prevalence and Drug Utilization Pattern in the Management of Type 2 Diabetes Mellitus and its Comorbidity with Cardiovascular Diseases: A Comparative Study. Indian J Pharm Sci. 2015;77(4):478-84doi: 10.4103/0250-474x.164776.
Das, S., Haroled Peter, P. L., Bhavani, M. L., Naresh, P., & Ramana, M. V. (2015). Age- and Sex-related Prevalence and Drug Utilization Pattern in the Management of Type 2 Diabetes Mellitus and its Comorbidity with Cardiovascular Diseases: A Comparative Study. Indian journal of pharmaceutical sciences, 77(4), 478-84. https://doi.org/10.4103/0250-474x.164776
Das, S, et al. "Age- and Sex-related Prevalence and Drug Utilization Pattern in the Management of Type 2 Diabetes Mellitus and its Comorbidity with Cardiovascular Diseases: A Comparative Study." Indian journal of pharmaceutical sciences vol. 77,4 (2015): 478-84. doi: https://doi.org/10.4103/0250-474x.164776
Das S, Haroled Peter PL, Bhavani ML, Naresh P, Ramana MV. Age- and Sex-related Prevalence and Drug Utilization Pattern in the Management of Type 2 Diabetes Mellitus and its Comorbidity with Cardiovascular Diseases: A Comparative Study. Indian J Pharm Sci. 2015 Jul-Aug;77(4):478-84. doi: 10.4103/0250-474x.164776. PMID: 26664065; PMCID: PMC4649794.
Copy Download .nbib Format: NLM
Multi-Omic Data Interpretation to Repurpose Subtype Specific Drug Candidates for Breast Cancer.

Frontiers in genetics

Turanli B, Karagoz K, Bidkhori G, Sinha R, Gatza ML, Uhlen M, Mardinoglu A, Arga KY.
PMID: 31134131
Front Genet. 2019 May 07;10:420. doi: 10.3389/fgene.2019.00420. eCollection 2019.

Triple-negative breast cancer (TNBC), which is largely synonymous with the basal-like molecular subtype, is the 5th leading cause of cancer deaths for women in the United States. The overall prognosis for TNBC patients remains poor given that few treatment...

Cite
Turanli B, Karagoz K, Bidkhori G, et al. Multi-Omic Data Interpretation to Repurpose Subtype Specific Drug Candidates for Breast Cancer. Front Genet. 2019;10:420doi: 10.3389/fgene.2019.00420.
Turanli, B., Karagoz, K., Bidkhori, G., Sinha, R., Gatza, M. L., Uhlen, M., Mardinoglu, A., & Arga, K. Y. (2019). Multi-Omic Data Interpretation to Repurpose Subtype Specific Drug Candidates for Breast Cancer. Frontiers in genetics, 10420. https://doi.org/10.3389/fgene.2019.00420
Turanli, Beste, et al. "Multi-Omic Data Interpretation to Repurpose Subtype Specific Drug Candidates for Breast Cancer." Frontiers in genetics vol. 10 (2019): 420. doi: https://doi.org/10.3389/fgene.2019.00420
Turanli B, Karagoz K, Bidkhori G, Sinha R, Gatza ML, Uhlen M, Mardinoglu A, Arga KY. Multi-Omic Data Interpretation to Repurpose Subtype Specific Drug Candidates for Breast Cancer. Front Genet. 2019 May 07;10:420. doi: 10.3389/fgene.2019.00420. eCollection 2019. PMID: 31134131; PMCID: PMC6514249.
Copy Download .nbib Format: NLM
Vasoactive-Inotropic Score and Vasoactive-Ventilation-Renal Score as Outcome Predictors for Children on Extracorporeal Membrane Oxygenation.

Frontiers in pediatrics

Shukla I, Hanson SJ, Yan K, Zhang J.
PMID: 34917562
Front Pediatr. 2021 Nov 30;9:769932. doi: 10.3389/fped.2021.769932. eCollection 2021.

We aimed to determine the association of vasoactive-inotropic score (VIS) and vasoactive-ventilation-renal (VVR) score with in-hospital mortality and functional outcomes at discharge of children who receive ECMO. A sub-analysis of the multicenter, prospectively collected data by the Collaborative Pediatric...

Cite
Shukla I, Hanson SJ, Yan K, et al. Vasoactive-Inotropic Score and Vasoactive-Ventilation-Renal Score as Outcome Predictors for Children on Extracorporeal Membrane Oxygenation. Front Pediatr. 2021;9:769932doi: 10.3389/fped.2021.769932.
Shukla, I., Hanson, S. J., Yan, K., & Zhang, J. (2021). Vasoactive-Inotropic Score and Vasoactive-Ventilation-Renal Score as Outcome Predictors for Children on Extracorporeal Membrane Oxygenation. Frontiers in pediatrics, 9769932. https://doi.org/10.3389/fped.2021.769932
Shukla, Ira, et al. "Vasoactive-Inotropic Score and Vasoactive-Ventilation-Renal Score as Outcome Predictors for Children on Extracorporeal Membrane Oxygenation." Frontiers in pediatrics vol. 9 (2021): 769932. doi: https://doi.org/10.3389/fped.2021.769932
Shukla I, Hanson SJ, Yan K, Zhang J. Vasoactive-Inotropic Score and Vasoactive-Ventilation-Renal Score as Outcome Predictors for Children on Extracorporeal Membrane Oxygenation. Front Pediatr. 2021 Nov 30;9:769932. doi: 10.3389/fped.2021.769932. eCollection 2021. PMID: 34917562; PMCID: PMC8669802.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 58 entries